Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises (...)
Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines (...)
Site référencé: The Economic Times
The Economic Times
Can Cholamandalam Investment maintain its AUM growth target in a challenging market ? CFO Arul Selvan answers
4/08/2025
Jyoti Global Plast IPO opens today with healthy GMP buzz. Check details
4/08/2025
Dollar steadies after tumble as investors eye imminent Fed cuts
4/08/2025
Wall Street banks lose ground in Europe as tariffs spook clients
4/08/2025
Near-term strategy for stocks with high futures rollover
4/08/2025
RBI's $5 billion forex swap maturity set to impact banking liquidity
4/08/2025
